The increasing incidences of infectious diseases, the outbreak of the COVID-19 pandemic, and the rising emphasis of governments of different nations on strengthening biodefense are the key factors driving
The Global Biosurveillance Market size is forecast to reach USD 5.62 Billion USD 3.80 Billion in 2019, to deliver a CAGR of 5% through 2027. The market growth is driven by the outbreak of deadly viruses and infections like the H1N1 Influenza outbreak, anthrax attacks, and SARS outbreak, creating an imminent need for preparedness in cases of bioterrorism.
Biosurveillance is an active data-gathering with appropriate analysis as well as interpretation of biosphere data related to disease activity and threats to animal or human health. These threats could be infectious, metabolic, toxic, of natural origin, or otherwise. Biosurveillance is integral to the process of achieving early warning of such health threats, early detection and management of health events, and awareness of disease activity. It enables early detection of disease outbreaks and provides the public and decision-makers with accurate and timely information to prevent, manage, or mitigate disease outbreaks. The rising incidence of chronic infections and disease outbreaks will foster the biosurveillance market share.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2991
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Key companies profiled in the report include:
Bitscopic, NanoViricides, Inc., Hawkeye Systems, Inc., Co-Diagnostics, Inc., Novavax, Inc., Gilead Sciences, Dynport Vaccine Company LLC, Bavarian Nordic, Cleveland Biolabs, and B.Ichor Medical Systems, among others
Market Segmentation by Types:
Type Outlook (Revenue, USD Billion; 2017-2027)
- Syndromic Surveillance
- Alternative Surveillance Systems
- Laboratory Surveillance
- Environmental Surveillance
Technology & equipment Outlook (Revenue, USD Billion; 2017-2027)
- Biocontainment technology & equipment
- Detection technology & equipment
- Protection technology & equipment
Application Outlook (Revenue, USD Billion; 2017-2027)
- Human and animal populations
- Water
- Food
- Agriculture
- Environment
End-use Outlook (Revenue, USD Billion; 2017-2027)
- Biosurveillance
- Threat reduction
- Biosecurity
- Disaster response
- Medical intelligence
End-user Outlook (Revenue, USD Billion; 2017-2027)
- Government administrative bodies
- Research organizations
- Healthcare organization and laboratory
- Government contractors
- Academic centers and think tanks
Order this Report @ https://www.reportsanddata.com/report-pricing/2991
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Biosurveillance market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Further key findings from the report suggest
- Based on type, the syndromic surveillance segment accounted for 40% of the biosurveillance market share in 2019 and is estimated to generate major revenue growth through 2027 due to its wide application in the public health sector. The syndromic surveillance turns quite effective for health departments to identify the disease incidence rate prior to any formal diagnosis. This has also aided in responding to the outbreaks like COVID-19 in an effective manner across several countries.
- In terms of technology & equipment, the detection technology & equipment segment accounted for nearly 45% of the biosurveillance market share in 2019 and is set to witness substantial growth over the forecast period on account of increasing emphasis on surveillance for the early detection of health events and detection of a disease outbreak. Some of the significant and widely used detection technology & equipment are Autonomous Pathogen Detection System, the Joint Biological Agent Identification and Diagnostic System (JBAIDS), Biological Materials, CANARY, and MASINTCell, among others.
- On the basis of application, the human and animal populations segment accounted for 40 % of the biosurveillance market share in 2019 and is likely to witness major growth through 2027 due to the fact that biological attacks like anthrax or major disease outbreak like COVID-19 or attacks have a direct impact on the human population, which makes surveillance on human and animal population to control such outbreaks.
- The medical intelligence segment is estimated to contribute significantly to the biosurveillance market revenue share and is set to exhibit a growth rate of 6 % during the forecast period.
- In the regional landscape, North America dominated the landscape with 35 % of the market share in 2019 and is estimated to witness major growth through 2027 due to technological advancements and a huge amount of funding allocated to biosurveillance & biodefense in the region. As of 15th October 2020, there were 8,150,383 COVID-19 cases in the U.S., which has further created lucrative opportunities for regional industry growth.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2991
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.
Browse More Reports:
Palbociclib Market @ https://www.biospace.com/article/palbociclib-market-share-size-key-players-trends-competitive-and-regional-forecast-to-2026/
Ibuprofen Market @ https://www.biospace.com/article/ibuprofen-market-analysis-development-opportunities-future-growth-and-business-prospects-by-forecast-to-2027/
Foot And Mouth Disease (FMD) Vaccine Market @ https://www.biospace.com/article/foot-and-mouth-disease-fmd-vaccine-market-analysis-statistics-revenue-and-trend-analysis-research-report-by-2026/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
